Medical News

RSS

Doctors still waiting for Capitol Hill action on Medicare payment cuts

The Wall Street Journal: The Senate continues to weigh a bill with wide-ranging provisions, including a postponement of the scheduled Medicare pay cut for doctors, but Democratic leaders appear to be having difficulty finding a plan that will appeal to members. "Repeated short-term fixes in recent years have left doctors frustrated and some … are refusing to take new Medicare patients.

17 Jun 2010

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

AGA Medical Holdings, Inc. today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER® Cardiac Plug clinical trial. Dr. William Nicholson, an interventional cardiologist and structural heart specialist at York Hospital in Pennsylvania, enrolled the first patient.

16 Jun 2010

Health on The Hill – June 15, 2010

Kaiser Health News staff writer Mary Agnes Carey and the Los Angeles Times' Noam Levey talk with KFF's Jackie Judd about recent events in Congress. For instance, the Senate is debating ways to reverse a 21 percent cut in Medicare physician payments that began on June 1.

16 Jun 2010

Fortis International Oncology Centre equipped with Varian's advanced radiotherapy equipment

The first in a planned series of new radiotherapy centers aimed at improving access to advanced treatments for millions of Indian cancer patients has been officially opened in Noida. Fortis International Oncology Centre, a joint initiative between International Oncology and Fortis Healthcare, is equipped with advanced radiotherapy equipment and software from Varian Medical Systems.

16 Jun 2010

Also in Global Health News: Clinton to Haiti; Global Fund suspends Zambian aid; Ugandan health workers; MDG summit; Rwandan health insurance; HIV drugs in Kenya

Reuters reports that former President Bill Clinton will return to Haiti to "jump-start" the country's post-earthquake reconstruction. Clinton will head the first meeting of Haiti's reconstruction commission, "part of a sorely needed effort to better coordinate international aid efforts, [Prime Minister Jean-Max] Bellerive said." Bellerive hopes the meeting will "establish clear-cut guidelines" for distributing more than $5 billion in aid from 140 countries following the Jan. 12 earthquake (Brown, 6/16).

16 Jun 2010

USPTO issues patent covering Probuphine for opiate addiction

Titan Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued patent number 7,736,665 covering Probuphine for the treatment of opiate addiction.

16 Jun 2010

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Oncodesign Biotechnology(R) announced today that it has signed a licensing agreement with Janssen Pharmaceutica NV (hereinafter Janssen) related to Janssen’s macrocyclic chemistry technology. Oncodesign will have exclusive access to this technology for six years.

16 Jun 2010

Dietary guideline on sodium puts Americans at risk

The Dietary Guidelines Advisory Committee (DGAC) of the U.S. Department of Health and Human Services and the U.S. Department of Agriculture may increase health risks, including obesity, by ignoring sound science as they announce recommendations to reduce sodium consumption to 1,500 mg per day, says the Salt Institute.

16 Jun 2010

Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome

Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.

16 Jun 2010

New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals

An article published in the May 2010 issue of Postgraduate Medicine highlights the seriousness of cardiovascular disease (CVD) in patients with type 2 diabetes. Cardiovascular disease is the cause of death in > 65% of patients with diabetes, and when complicated by the presence of obesity, the lifetime risk of developing CVD increases to 90%. The inherent problem is that many of the antihyperglycemic medications used to combat high glycated hemoglobin are associated with weight gain and/or hypoglycemia, which negatively affect CVD.

16 Jun 2010

A review of the response to oral anti-diabetes agents in patients with type 2 diabetes

Patients with type 2 diabetes show a progressive decline in glycemic control and receive antidiabetic therapy in order to reach the target glycated hemoglobin level of < 7% set by the American Diabetes Association and the European Association for the Study of Diabetes. An article published in the May 2010 issue of Postgraduate Medicine reviews the effectiveness of oral antidiabetes (OAD) agents in maintaining glycemic control in patients with type 2 diabetes.

16 Jun 2010

How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiation

Type 2 diabetes is characterized by unsatisfactory levels of glycated hemoglobin (HbA1c) for extended periods. An article published in the May 2010 edition of Postgraduate Medicine reports a proposal to shorten the total time spent with uncontrolled hyperglycemia by minimizing the number of steps along the treatment-intensification ladder. In doing so, patients would decrease their exposure to hyperglycemia and potentially improve long-term outcomes.

16 Jun 2010

The utility of observational studies in clinical decision making: Lessons learned from statin trials

An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.

16 Jun 2010

Meningococcal disease in infants: A potentially difficult and serious diagnosis

An article published in the May 2010 edition of Postgraduate Medicine documents a case study where a previously healthy, 15-week-old male infant was misdiagnosed and died of meningococcal disease. Initially the patient showed signs of the common cold and was treated as such, but symptoms worsened and he was admitted to the hospital emergency department.

16 Jun 2010

TEREC member Dental Prosthetic Services joins SensAble Authorized Production Center Program

SensAble Technologies, Inc, the leading provider of dental restoration design and fabrication solutions, haptic devices and 3D modeling software, announced that Dental Prosthetic Services has joined the SensAble Authorized Production Center (SAPC) Program.

16 Jun 2010

New independent study demonstrates clinical accuracy of Masimo noninvasive and continuous hemoglobin monitoring

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new independent study demonstrating the clinical accuracy of Masimo noninvasive and continuous hemoglobin (SpHb) monitoring was presented this week at the European Society of Anaesthesiology (ESA) Annual Congress in Helsinki, Finland.

16 Jun 2010

EMS announces availability of SIM-EMR application for training medical and nursing students

Education Management Solutions, the world leader in simulation management and skills evaluation software and audio-video technology, announced today at the International Nursing Association for Clinical Simulation and Learning conference in Las Vegas, the availability of a simulated Electronic Medical Record application for training.

16 Jun 2010

Trius Therapeutics reaches agreement with FDA under SPA for Phase 3 study of torezolid phosphate for ABSSSI

Trius Therapeutics, Inc. announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study for the oral dosage form of torezolid phosphate for treatment of acute bacterial skin and skin structure infections (ABSSSI).

16 Jun 2010

Zotec Partners renews contract with MRIA to continue licensing its software

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems software and services, announces today that McHenry Radiologists & Imaging Associates, out of McHenry, Ill.,‎ has renewed its contract with the company for five years to continue licensing its software.

16 Jun 2010

PRA International Clinical Research Organization opens Phase I facility in Budapest

PRA International, a leading Clinical Research Organization, announces the opening of a Phase I facility in Budapest, Hungary that will provide "unit-on-demand" service and further enhance PRA's capabilities for conducting early-development trials in patients.

16 Jun 2010

Medical News

Doctors still waiting for Capitol Hill action on Medicare payment cuts

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

Health on The Hill – June 15, 2010

Fortis International Oncology Centre equipped with Varian's advanced radiotherapy equipment

Also in Global Health News: Clinton to Haiti; Global Fund suspends Zambian aid; Ugandan health workers; MDG summit; Rwandan health insurance; HIV drugs in Kenya

USPTO issues patent covering Probuphine for opiate addiction

Oncodesign announces technology license agreement with Janssen Pharmaceutica

Dietary guideline on sodium puts Americans at risk

Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome

New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals

A review of the response to oral anti-diabetes agents in patients with type 2 diabetes

How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiation

The utility of observational studies in clinical decision making: Lessons learned from statin trials

Meningococcal disease in infants: A potentially difficult and serious diagnosis

TEREC member Dental Prosthetic Services joins SensAble Authorized Production Center Program

New independent study demonstrates clinical accuracy of Masimo noninvasive and continuous hemoglobin monitoring

EMS announces availability of SIM-EMR application for training medical and nursing students

Trius Therapeutics reaches agreement with FDA under SPA for Phase 3 study of torezolid phosphate for ABSSSI

Zotec Partners renews contract with MRIA to continue licensing its software

PRA International Clinical Research Organization opens Phase I facility in Budapest

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News